deferoxamine has been researched along with nifedipine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fryer, PR; Green, CJ; Pickford, MA; Sarathchandra, P | 1 |
| Bhatnagar, A; Castro, GJ | 1 |
| Anghileri, LJ; Thouvenot, P | 1 |
| Hattori, Y; Kanno, M; Kawasaki, H; Matsuda, N; Sato, A; Tomioka, H; Watanuki, S | 1 |
| Higo, A; Katsura, M; Mohri, Y; Ohkuma, S; Shirotani, K; Shuto, K; Takesue, M; Tarumi, C | 1 |
| Castilho, RF; Degasperi, GR; Vercesi, AE | 1 |
| Chattipakorn, N; Chattipakorn, S; Chinda, K; Fucharoen, S; Kumfu, S | 1 |
1 review(s) available for deferoxamine and nifedipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for deferoxamine and nifedipine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Ultrastructural changes in rat lungs after 48 h cold storage with and without reperfusion.
Topics: Allopurinol; Animals; Basement Membrane; Cryopreservation; Deferoxamine; Endothelium, Vascular; Epoprostenol; Lung; Lung Transplantation; Microscopy, Electron; Nifedipine; Organ Preservation; Rats; Rats, Inbred Strains; Reperfusion Injury; Time Factors; Verapamil | 1990 |
Effect of extracellular ions and modulators of calcium transport on survival of tert-butyl hydroperoxide exposed cardiac myocytes.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cell Size; Cell Survival; Deferoxamine; Diacetyl; Heart; Lipid Peroxidation; Male; Myocardium; Nifedipine; Oxidants; Peroxides; Propyl Gallate; Rats; Rats, Sprague-Dawley; Sodium; tert-Butylhydroperoxide; Verapamil | 1993 |
ATP in iron overload-induced intracellular calcium changes.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Carcinoma, Ehrlich Tumor; Deferoxamine; Dose-Response Relationship, Drug; Iron; Iron Chelating Agents; Iron Overload; Lactic Acid; Lanthanum; Lipid Peroxidation; Nifedipine; Sodium; Trifluoperazine | 1998 |
Predominant contribution of the G protein-mediated mechanism to NaF-induced vascular contractions in diabetic rats: association with an increased level of G(qalpha) expression.
Topics: Aluminum Chloride; Aluminum Compounds; Animals; Aorta, Thoracic; Astringents; Blotting, Western; Chelating Agents; Chlorides; Deferoxamine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; GTP-Binding Proteins; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Nifedipine; Okadaic Acid; Rats; Rats, Wistar; Sodium Fluoride; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Suppression of Ca2+ influx through L-type voltage-dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Deferoxamine; Ferrous Compounds; Free Radical Scavengers; Hydrogen Peroxide; Hydroxyl Radical; Ion Channel Gating; Ion Transport; Iron Chelating Agents; Mannitol; Mice; Nerve Tissue Proteins; Neurons; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Potassium Chloride; Thiourea | 2001 |
High susceptibility of activated lymphocytes to oxidative stress-induced cell death.
Topics: Animals; Apoptosis; Calcium; Carcinoma 256, Walker; Chelating Agents; Deferoxamine; Egtazic Acid; Flow Cytometry; Lymphocyte Activation; Lymphocytes; Male; Membrane Potentials; Mitochondria; Nifedipine; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Siderophores; Spleen; tert-Butylhydroperoxide; Time Factors | 2008 |
T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
Topics: Animals; Azoles; Base Sequence; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular System; Deferoxamine; Dihydropyridines; Disease Models, Animal; DNA Primers; Heart Rate; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nifedipine; Nitrophenols; Organ Size; Organophosphorus Compounds; Organoselenium Compounds; RNA, Messenger; Ventricular Function, Left; Verapamil | 2012 |